Watcharin Loilome Selected Research

Cholangiocarcinoma

1/2022	Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.
10/2021	Mapping of population disparities in the cholangiocarcinoma urinary metabolome.
10/2021	Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.
9/2021	Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma.
8/2021	Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma.
5/2021	Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma.
4/2021	Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse.
3/2021	Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models.
1/2021	Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction.
1/2021	Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Watcharin Loilome Research Topics

Disease

80	Cholangiocarcinoma 01/2022 - 01/2008
53	Neoplasms (Cancer) 10/2021 - 03/2011
16	Opisthorchiasis 06/2022 - 03/2012
16	Infections 01/2019 - 05/2006
15	Inflammation (Inflammations) 01/2021 - 01/2012
12	Neoplasm Metastasis (Metastasis) 10/2021 - 03/2010
10	Carcinogenesis 01/2018 - 03/2011
7	Fibrosis (Cirrhosis) 01/2019 - 12/2012
5	Digestive System Diseases 01/2020 - 04/2013
3	Body Weight (Weight, Body) 10/2021 - 03/2017
3	Hepatocellular Carcinoma (Hepatoma) 02/2020 - 01/2012
2	Lymphatic Metastasis 02/2020 - 08/2014
2	Reinfection 01/2017 - 05/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2012 - 09/2009
1	Pathologic Constriction (Stenosis) 01/2020
1	Liver Diseases (Liver Disease) 01/2020

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2021 - 03/2012
10	Biomarkers (Surrogate Marker)IBA 08/2021 - 03/2014
9	Pharmaceutical PreparationsIBA 10/2021 - 01/2008
7	EnzymesIBA 01/2021 - 01/2012
6	Cadherins (E-Cadherin)IBA 10/2021 - 12/2012
6	Praziquantel (Biltricide)FDA Link 01/2021 - 01/2016
5	AntioxidantsIBA 01/2021 - 01/2012
5	AntigensIBA 01/2019 - 03/2012
5	Messenger RNA (mRNA)IBA 09/2014 - 03/2010
5	OxysterolsIBA 01/2014 - 03/2011
4	Gemcitabine FDA Link 01/2022 - 01/2018
4	LipidsIBA 01/2021 - 01/2018
4	xanthohumolIBA 05/2020 - 01/2012
3	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 12/2014 - 04/2013
2	Formaldehyde (Formol)FDA Link 06/2022 - 01/2015
2	ethyl acetateIBA 06/2022 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2021
2	Biological ProductsIBA 10/2021 - 01/2018
2	Cell Adhesion MoleculesIBA 10/2021 - 09/2014
2	Protein Kinases (Protein Kinase)IBA 02/2020 - 11/2017
2	ErbB Receptors (EGF Receptor)IBA 02/2020 - 01/2017
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2012
2	Amino Acids FDA Link 01/2020 - 03/2017
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2019 - 01/2018
2	Transferrin (beta 2 Transferrin)IBA 01/2019 - 07/2017
2	ResveratrolIBA 10/2018 - 01/2018
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2018 - 12/2013
2	IronIBA 01/2018 - 07/2017
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018 - 08/2017
2	Phosphotransferases (Kinase)IBA 11/2017 - 12/2013
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2017 - 01/2017
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 08/2017 - 03/2017
2	MicroRNAs (MicroRNA)IBA 08/2017 - 12/2014
2	ImmunosorbentsIBA 01/2017 - 01/2015
2	AutoantibodiesIBA 01/2015 - 12/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 12/2012
2	Dinoprostone (PGE2)FDA Link 08/2014 - 01/2012
2	CateninsIBA 06/2014 - 01/2014
2	CholesterolIBA 01/2014 - 03/2012
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 12/2012
2	Prednisolone (Predate)FDA LinkGeneric 01/2013 - 06/2012
2	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2013 - 05/2006
2	CytokinesIBA 05/2012 - 01/2012
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2012 - 03/2012
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2012 - 07/2011
1	7-methylguanineIBA 10/2021
1	PseudouridineIBA 10/2021
1	UridineIBA 10/2021
1	XenobioticsIBA 10/2021
1	NucleotidesIBA 10/2021
1	arctigeninIBA 10/2021
1	Cell-Free Nucleic AcidsIBA 05/2021
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 03/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	pyrvinium (Vankin)FDA Link 01/2021
1	Inosine FDA Link 01/2021
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2021
1	AnthelminticsIBA 01/2021
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 01/2021
1	NestinIBA 01/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021
1	Acetyl-CoA CarboxylaseIBA 01/2021
1	coniferyl alcoholIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Sarcosine (Methylglycine)IBA 01/2021
1	TriterpenesIBA 12/2020
1	Ursolic AcidIBA 12/2020
1	FlavonoidsIBA 05/2020
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 02/2020
1	Vascular Endothelial Growth Factor CIBA 02/2020
1	Erythropoietin FDA Link 02/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2020
1	human ERBB2 proteinIBA 02/2020
1	beta CateninIBA 02/2020
1	Aspartic Acid (Aspartate)FDA Link 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020

Therapy/Procedure

9	Therapeutics 11/2019 - 01/2012
4	Drug Therapy (Chemotherapy) 04/2021 - 07/2016
3	Aftercare (After-Treatment) 09/2021 - 02/2020
2	Oral Administration 01/2020 - 08/2018
1	Precision Medicine 09/2021
1	Synchrotrons 12/2020